PRTA

8.97

1.43% -0.13

Dopo l'orario di chiusura: 8.90 -0.07 -0.78%

Prothena Corporation Plc (PRTA)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché PRTA Giù? Forum Previsione

Precedente Chiudi:

$9.10

Aprire:

$9.01

Volume 24 ore:

636.41K

Relative Volume:

0.99

Capitalizzazione di mercato:

$482.85M

Reddito:

$217.25M

Utile/perdita netta:

$-50.92M

Rapporto P/E:

-8.97

EPS:

-1

Flusso di cassa netto:

$-100.85M

1 W Prestazione:

-3.65%

1M Prestazione:

-18.97%

6M Prestazione:

+39.39%

1 anno Prestazione:

-31.79%

Intervallo 1D:

$8.885

$9.14

Intervallo di 1 settimana:

$8.885

$9.69

Portata 52W:

$4.32

$16.66

Prothena Corporation Plc Stock (PRTA) Company Profile

Nome

Prothena Corporation Plc

Settore

Healthcare (1114)

Industria

Biotechnology (625)

Telefono

011-353-1-236-2500

Indirizzo

77 SIR JOHN ROGERSON'S QUAY, BLOCK C, DUBLIN 2

Dipendente

163

Cinguettio

@ProthenaCorp

Prossima data di guadagno

2025-02-18

Ultimi documenti SEC

PRTA's Discussions on Twitter

Confronta PRTA con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
PRTA Prothena Corporation Plc	8.97	489.85M	217.25M	-50.92M	-100.85M	-1.00
VRTX Vertex Pharmaceuticals Inc	468.38	113.87B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	776.54	80.22B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	406.40	52.56B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	803.74	49.31B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	175.07	37.37B	447.02M	-1.18B	-906.14M	-6.1812

Prothena Corporation Plc Stock (PRTA) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-05-28	Downgrade	BofA Securities	Neutral → Underperform
2025-05-27	Downgrade	Cantor Fitzgerald	Overweight → Neutral
2025-05-27	Downgrade	Jefferies	Buy → Hold
2025-05-27	Downgrade	Oppenheimer	Outperform → Perform
2024-12-20	Iniziato	Chardan Capital Markets	Buy
2024-01-30	Downgrade	BofA Securities	Buy → Neutral
2023-12-12	Iniziato	Deutsche Bank	Buy
2023-04-24	Iniziato	SVB Securities	Outperform
2023-01-27	Iniziato	Piper Sandler	Overweight
2022-11-04	Downgrade	RBC Capital Mkts	Outperform → Sector Perform
2022-09-28	Aggiornamento	BofA Securities	Neutral → Buy
2021-11-19	Iniziato	JMP Securities	Mkt Outperform
2021-06-18	Aggiornamento	BofA Securities	Underperform → Neutral
2021-06-08	Reiterato	Oppenheimer	Outperform
2021-05-26	Iniziato	Citigroup	Buy
2021-02-26	Aggiornamento	RBC Capital Mkts	Sector Perform → Outperform
2021-02-12	Aggiornamento	Jefferies	Hold → Buy
2021-02-02	Aggiornamento	BTIG Research	Neutral → Buy
2020-12-07	Iniziato	H.C. Wainwright	Buy
2020-07-09	Aggiornamento	Oppenheimer	Perform → Outperform
2019-11-19	Aggiornamento	Evercore ISI	In-line → Outperform
2018-05-21	Downgrade	Barclays	Equal Weight → Underweight
2018-04-23	Downgrade	Jefferies	Buy → Hold
2018-04-05	Reiterato	Barclays	Overweight
2017-11-20	Downgrade	Wedbush	Outperform → Neutral
2017-09-29	Reiterato	BTIG Research	Buy
2017-09-15	Iniziato	RBC Capital Mkts	Outperform
2017-08-17	Iniziato	Evercore ISI	Outperform
2017-07-11	Iniziato	Jefferies	Buy
2017-04-12	Iniziato	Cantor Fitzgerald	Overweight
2017-04-12	Iniziato	Piper Jaffray	Overweight
2017-03-02	Iniziato	Instinet	Buy
2016-12-21	Iniziato	SunTrust	Buy
2016-11-03	Iniziato	Deutsche Bank	Buy
2016-08-04	Reiterato	Barclays	Overweight
2016-05-13	Iniziato	Barclays	Overweight
2016-02-19	Reiterato	Wedbush	Outperform
2016-01-21	Iniziato	Credit Suisse	Outperform

Mostra tutto

Prothena Corporation Plc Borsa (PRTA) Ultime notizie

Jan 05, 2026

How Are Partnered Pipelines Rewriting The Prothena (PRTA) Narrative And Price Target Outlook - Yahoo Finance UK

Jan 05, 2026

Macro Review: What valuation multiples suggest for Prothena Corporation plc stockWeekly Profit Summary & Long Hold Capital Preservation Plans - moha.gov.vn

Jan 05, 2026

Jan 02, 2026

We Think Prothena (NASDAQ:PRTA) Can Afford To Drive Business Growth - Yahoo Finance

Jan 02, 2026

(PRTA) and the Role of Price-Sensitive Allocations - Stock Traders Daily

Jan 02, 2026

Dec 26, 2025

Prothena announces board of directors update - MSN

Dec 26, 2025

Dec 25, 2025

89,704 Shares in Prothena Corporation plc $PRTA Acquired by Assenagon Asset Management S.A. - Defense World

Dec 25, 2025

Dec 22, 2025

(PRTA) Movement as an Input in Quant Signal Sets - Stock Traders Daily

Dec 22, 2025

Dec 21, 2025

Prothena Corporation plc(NasdaqGS:PRTA) added to S&P Biotechnology Select Industry Index - marketscreener.com

Dec 21, 2025

Squarepoint Ops LLC Takes $1.27 Million Position in Prothena Corporation plc $PRTA - Defense World

Dec 21, 2025

Dec 20, 2025

Earnings Miss: Why Prothena Corporation plc stock remains undervaluedStock Surge & Fast Entry Momentum Trade Alerts - Улправда

Dec 20, 2025

Dec 19, 2025

Why Prothena Corporation plc stock remains undervaluedDip Buying & Free High Return Stock Watch Alerts - Улправда

Dec 19, 2025

What catalysts could drive Prothena Corporation plc stock higherDip Buying & AI Based Trade Execution Alerts - DonanımHaber

Dec 19, 2025

Dec 17, 2025

Prothena Corporation plc (NASDAQ:PRTA) Given Average Recommendation of "Hold" by Analysts - MarketBeat

Dec 17, 2025

Dec 13, 2025

Birchview Capital LP Has $2.74 Million Stock Holdings in Prothena Corporation plc $PRTA - MarketBeat

Dec 13, 2025

Prothena Board Member Paula Cobb Resigns - The Globe and Mail

Dec 13, 2025

Dec 12, 2025

Paula Cobb steps down from Prothena’s board to join Manifold Bio - Investing.com Nigeria

Dec 12, 2025

Paula Cobb steps down from Prothena’s board to join Manifold Bio By Investing.com - Investing.com South Africa

Dec 12, 2025

[8-K] PROTHENA CORP PUBLIC LTD CO Reports Material Event | PRTA SEC FilingForm 8-K - Stock Titan

Dec 12, 2025

Prothena Announces Board of Directors Update - Yahoo Finance

Dec 12, 2025

What analysts say about Prothena Corporation plc stockMean Reversion Trades & Free Harness Proven Investment Plans - earlytimes.in

Dec 12, 2025